Keppra XR



Indications and Reactions:

Role Indications Reactions
Primary
Convulsion 31.5%
Epilepsy 21.3%
Vitamin Supplementation 8.1%
Pregnancy 7.6%
Anxiety 5.2%
Headache 4.8%
Dyspepsia 4.4%
Anaemia 2.8%
Partial Seizures 1.9%
Sleep Disorder 1.9%
Asthma 1.7%
Hypertension 1.5%
Migraine 1.5%
Depression 1.3%
Rhinitis Allergic 1.1%
Pain 0.9%
Coronary Artery Disease 0.7%
Grand Mal Convulsion 0.7%
Cardiac Disorder 0.6%
Gastrooesophageal Reflux Disease 0.6%
Convulsion 19.7%
Death 15.9%
Inappropriate Schedule Of Drug Administration 11.4%
Pregnancy 6.1%
Cerebrovascular Accident 5.3%
Premature Baby 4.5%
Foetal Exposure During Pregnancy 3.8%
Myocardial Infarction 3.8%
Pneumonia 3.8%
Product Substitution Issue 3.8%
Road Traffic Accident 3.8%
Overdose 3.0%
Fall 2.3%
Headache 2.3%
Trisomy 21 2.3%
Upper Respiratory Tract Infection 2.3%
Abortion Spontaneous 1.5%
Alopecia 1.5%
Dyspepsia 1.5%
Eye Operation 1.5%
Secondary
Epilepsy 29.8%
Convulsion 23.3%
Pregnancy 18.0%
Vitamin Supplementation 9.7%
Headache 3.3%
Dyspepsia 2.9%
Anxiety 2.4%
Anaemia 1.9%
Migraine 1.3%
Sleep Disorder 1.3%
Hypertension 1.0%
Partial Seizures 1.0%
Blood Iron Decreased 0.7%
Rhinitis Allergic 0.7%
Asthma 0.6%
Blood Pressure 0.5%
Gestational Diabetes 0.5%
Hypersensitivity 0.5%
Depression 0.4%
Drug Use For Unknown Indication 0.4%
Convulsion 16.4%
Pregnancy 10.3%
Premature Baby 9.5%
Foetal Exposure During Pregnancy 8.6%
Inappropriate Schedule Of Drug Administration 7.8%
Breast Feeding 4.3%
Pre-eclampsia 4.3%
Drug Exposure During Pregnancy 3.4%
Grand Mal Convulsion 3.4%
Stress 3.4%
Upper Respiratory Tract Infection 3.4%
Urachal Abnormality 3.4%
Vitamin B12 Decreased 3.4%
Abortion Spontaneous 2.6%
Haemangioma 2.6%
Overdose 2.6%
Petit Mal Epilepsy 2.6%
Product Substitution Issue 2.6%
Rhabdomyolysis 2.6%
Road Traffic Accident 2.6%
Concomitant
Hypertension 15.0%
Convulsion 10.3%
Epilepsy 9.5%
Laryngospasm 9.5%
Product Used For Unknown Indication 8.3%
Pain 5.7%
Multiple Sclerosis 4.9%
Depression 3.4%
Hiccups 3.4%
Anxiety 3.1%
Tremor 3.1%
Drug Use For Unknown Indication 2.9%
Dehydration 2.8%
Gastric Haemorrhage 2.8%
Infection Prophylaxis 2.8%
Insomnia 2.8%
Neuropathy Peripheral 2.8%
Pain Prophylaxis 2.8%
Sedative Therapy 2.8%
Glioblastoma Multiforme 1.7%
Progressive Multifocal Leukoencephalopathy 27.8%
Seizure Cluster 18.1%
Inappropriate Antidiuretic Hormone Secretion 8.3%
Convulsion 6.9%
Vomiting 5.6%
Product Quality Issue 4.2%
Pyrexia 4.2%
Visual Acuity Reduced 4.2%
Rash 2.8%
Skin Exfoliation 2.8%
Suicidal Ideation 2.8%
Abdominal Discomfort 1.4%
Abdominal Distension 1.4%
Anaemia 1.4%
Anaphylactic Reaction 1.4%
Burning Sensation 1.4%
Candidiasis 1.4%
Cataract 1.4%
Chronic Lymphocytic Leukaemia 1.4%
Clostridial Infection 1.4%
Interacting
Convulsion 44.4%
Product Used For Unknown Indication 33.3%
Pain 22.2%
Suicidal Ideation 100.0%